Pedro Perez: The VTE Market Is Clearly Entering Its Next Phase
Pedro Perez, Vascular Consultant – PERT and VTE Program Builder at Argon Medical Devices, Inc., shared on LinkedIn:
”The VTE market is clearly entering its next phase
With Penumbra joining Boston Scientific and Inari becoming part of Stryker, the two category-defining innovators are now backed by global strategics with massive scale, capital, and contracting power.
These companies earned their leadership through time in market, differentiated technology, clinical evidence, and deep physician trust — advantages that are hard to replicate.
What does this mean for the rest of the field?
The VTE space is increasingly crowded, but the available market share is limited.
New and emerging competitors are fighting uphill for protocol inclusion, value analysis approval, workflow adoption, and mindshare in labs already standardized around established platforms.
We’re shifting from an innovation-first era to a scale, execution, and economic-value era.
Going forward, success won’t come from “me too” devices — it will come from clear clinical differentiation, operational simplicity, and undeniable total cost impact.
Consolidation isn’t slowing competition.
It’s raising the bar.”
Stay updated with Hemostasis Today.
-
May 6, 2026, 11:30Paula Caporal: Consensus on the Diagnosis and Management of Pediatric Stroke in Argentina
-
May 6, 2026, 11:14Li Khim Kwah: Proud for the Development of The New Singapore Stroke Rehabilitation Guideline
-
May 6, 2026, 10:55Hugo Antonio Romo Rubio: A New Paradigm in Treatment for Hemophilia A from FRONTIERS2 Phase 3 Study
-
May 6, 2026, 10:40Ifeanyichukwu Ifechidere: Why INR Can Be Dangerously Misleading
-
May 6, 2026, 02:58Limiaa Babikir: What Is Polyspecific DAT?
-
May 6, 2026, 02:47Karen Rollinson: Connecting with so Many Families and Advocates at HFA 2026
-
May 6, 2026, 02:38Moustafa Abdou: Is the Bone Marrow Examination Still the ‘Gold Standard’?
-
May 6, 2026, 02:23Khaled Musallam: When the Worlds of Thalassemia and Hemophilia Converge
-
May 6, 2026, 02:12Caitlin Raymond: How STOP-BABESIOSIS Just Rewrote 40 Years of Practice